Day 2
Location: Room 2
From early development through to commercial manufacturing, service providers play an increasingly pivotal role in accelerating biopharma innovation. No longer behind-the-scenes, CDMOs, CROs, and enabling technology platforms are now strategic partners in development. This session brings together leaders from across the services spectrum to discuss how service providers provide critical expertise, infrastructure, and scalability, and contribute to value creation, derisking development timelines, and enable flexible go-to-market strategies. The panelists will explore how partnerships between biotech, pharma, and service providers have evolved, and what trends are shaping the future. As the ecosystem continues to shift toward greater specialization and collaboration, this panel will offer insights into how service providers can be powerful allies in building resilient, agile, and capital-efficient development strategies.
- Tom Murtagh - Global Practice Lead, Lumanity
- Maud Bouvier - Associate VP, Business Development, Evotec
- Ben Clauberg - VP Business Development Europe, AGC Biologics
- Matthieu Coutet - Partner, Sofinnova Partners
- Hartmut Juhl - CEO, Indivumed
- Steve Yang - Co-CEO, WuXi AppTec